Arrowbiome
1 known investors
ArrowBiome develops precision microbiome actives—including phage-derived enzymes and engineered particles—that selectively target bacteria linked to acne and body odour while preserving beneficial skin bacteria. It supplies these clinically validated, patent-protected ingredients to beauty and fragrance companies, from global multinationals to indie brands, through a global distributor network.
BiotechConsumerDeep Tech